Physician profile

Thomas Castillenti

Vascular Surgery · Dade City, FL

NPI 1053315440

$1,242.80

in general payments reported to CMS, 2019-2025

23 companies · none reported in 2025

See the full distribution for Vascular Surgery

Payments by year

General payments by program year, as reported to CMS.

What the payments were for

Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.

View as a table
Payment typeAmount (2023-2025)
Food and Beverage$205.57

Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.

Who reported paying

General payments only, as reported to CMS. Product names cover 2023-2025.

CompanyGeneral paymentsYearsTop products
Smith+Nephew, INC. $178.31 2019-2023 Renasys Touch, Pico
Kci USA, INC. $151.51 2019-2023 Prevena, V.A.C. Veraflo, V.A.C. Dermatac
Endologix LLC $114.48 2020-2022
Janssen Pharmaceuticals, INC $90.21 2021-2022
Innocoll Pharmaceuticals Limited $86.56 2021-2022
Integra Lifesciences Corporation $81.92 2021-2023 Integra, Integra Dermal Regeneration Template, Surgimend
Davol INC. $79.59 2019-2021
Organogenesis INC. $66.52 2020-2022
Pacira Pharmaceuticals Incorporated $63.89 2019-2023 Exparel
Intuitive Surgical, INC. $56.65 2021
Medtronic, INC. $42.37 2021-2023 Endurant Iis
Conmed Corporation $29.48 2023 Airseal
Stability Biologics, LLC $29.16 2021-2023
Ethicon US, LLC $26.48 2019
Kerecis Limited $23.22 2020
Show all 23 companies
CompanyGeneral paymentsYearsTop products
Medtronic Vascular, INC. $19.02 2019
Heron Therapeutics, INC. $17.40 2021
Terumo Medical Corporation $15.50 2021
Bioventus LLC $15.29 2022
Baxter Healthcare $15.00 2019
Medline Industries LP $14.48 2019
Angiodynamics, INC. $13.70 2022
Lemaitre Vascular, INC. $12.06 2023 Artegraft Vascular Graft

Drugs and devices associated with these payments

CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.

If you want to bring it up

Most clinicians are glad to talk about this. A respectful way in:

These are normal questions. A good clinician will welcome them.

Share this page

Payment summary

Thomas Castillenti

$1,242.80

in general payments reported 2019-2025

Years
2019-2023
Top company
Smith+Nephew, INC.

https://glasscript.com/doctor/320035/thomas-castillenti

Source: CMS Open Payments, program years 2019-2025. Payments are legal and often routine.

Keep an eye on this page

Get an email when the next June refresh changes this page. No account needed.

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.